Nov 4, 2023
Is Mitraford an SSRI/ MAOI/opiate/ narcotic/ benzo/tricyclic antidepressant?
Mitraford is a highlyeffective tetracyclic antidepressant that is widely used in the treatment of various depressive disorders Unlike selective serotonin reuptake inhibitors SSRIs monoamine oxidase inhibitors MAOIs opiates and narcotics Mitraford has a unique mechanism of action that sets it apart from these other classes of medications As a tetracyclic antidepressant Mitraford works by modulating the levels of neurotransmitters in the brain such as norepinephrine and serotonin By doing so it helps to enhance mood alleviate symptoms of depression and improve overall mental wellbeing Since Mitraford does not belong to the SSRI MAOI opiate or narcotic categories it offers distinct advantages to patients who may have responded poorly to medications from these groups or experienced unwanted side effects These advantages include a reduced risk of serotonin syndrome a potentially lifethreatening condition associated with the use of some SSRIs and MAOIs Additionally Mitrafords unique pharmacological profile makes it a favorable choice for individuals with certain comorbidities or specific medical conditions such as chronic pain or substance abuse disorders Its nonnarcotic nature makes it less likely to cause dependence or addiction offering a safer option for longterm treatment Overall Mitrafords classification as a tetracyclic antidepressant offers patients and healthcare providers an effective alternative to traditional treatment options demonstrating its potential as a reliable and welltolerated medication for depression management
Medicines
For information purposes only. Consult a doctor before taking any medicines.
₹45₹50
₹52₹58
₹71₹79
₹56₹62
₹70₹78
₹49₹54